enVVeno Medical Corporation
NVNO | NASDAQ
$9.06
+$0.01 (+0.11%)
Sep 22, 2026, 11:42 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -15.72M | -18.82M | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M | -20.6M | -22.12M | -23.52M | -24.05M | -25.14M | -25.73M | -24.67M | -27.48M | -23.77M | -19.08M | -16.53M | -11.91M | -11.5M | -10.75M |
Depreciation & Amortization | 390K | 491K | 489K | 494K | 503K | 509K | 528K | 540K | 549K | 551K | 546K | 542K | 537K | 532K | 525K | 516.59K | 503.59K | 477.59K | 452.59K | 426.98K | 405.52K | 401.91K |
Stock-Based Compensation | 2.19M | 3.24M | 3.42M | 3.8M | 4.12M | 3.68M | 4.14M | 4.27M | 4.37M | 4.52M | 5.2M | 6.29M | 7.4M | 8.54M | 8.99M | 12.1M | 10.21M | 8.11M | 6M | 1.17M | 1.04M | 879.32K |
Other Working Capital | -1.14M | 583K | 128K | 534K | 422K | -950K | -238K | -805K | -642K | -770K | -1.1M | -334K | -403K | -150K | -435K | -165.07K | 44.93K | -155.07K | -312.07K | 127.38K | -186.2K | -71.89K |
Other Non-Cash Items | 187K | 244K | 391K | 430K | 385K | 260K | 23K | 4K | -146K | -234K | -468K | -823K | -669K | -424K | -122K | 57.04K | -331.96K | -520.96K | -624.96K | -592.37K | -220.5K | -139.25K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.66M | 59K | -396K | 10K | 950K | -422K | 290K | -277K | -814K | -18K | -616K | 297K | -133K | -327K | -347K | -58.18K | 770.82K | -309.18K | -1.14M | -454.49K | -1.45M | -760.34K |
Operating Cash Flow | -14.62M | -14.79M | -15.57M | -17.23M | -17.11M | -17.31M | -16.84M | -16.71M | -16.64M | -17.3M | -18.86M | -17.74M | -18.01M | -17.41M | -15.62M | -14.86M | -12.61M | -11.32M | -11.85M | -11.36M | -11.72M | -10.37M |
Capital Expenditures | n/a | -5K | -5K | -9K | -18K | -27K | -37K | -37K | -31K | -38K | -33K | -38K | -49K | -51K | -115K | -170.75K | -308.75K | -412.75K | -367.75K | -330.54K | -203.51K | -198.98K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -70.03M | -59.39M | -46.02M | -48.85M | -47.31M | -49.31M | -55.57M | -65.66M | -66.49M | -63.03M | -56.52M | -30.19M | -24.94M | -56.76M | -48.13M | -42.21M | -38.29M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 84.3M | 72.82M | 61.88M | 49.48M | 50.51M | 53.67M | 56.94M | 55.95M | 54.99M | 54.57M | 48.69M | 50.02M | 38.64M | 25.15M | 13.69M | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.27M | 13.43M | 15.86M | 618K | 3.19M | 4.34M | 1.33M | -9.75M | -11.53M | -8.5M | -7.87M | 19.79M | 13.66M | -31.66M | -34.55M | -40.13M | -38.59M | -412.75K | -367.75K | -330.54K | -203.51K | -198.98K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 13.59M | 13.59M | 13.64M | 13.64M | 46K | 46K | n/a | n/a | n/a | n/a | n/a | 5.25K | 5.25K | 5.25K | 245.25K | 3.38M | 4.8M | 5.11M |
Financial Cash Flow | 1.15M | 1.02M | 1.02M | 241K | 13.59M | 13.59M | 13.64M | 39.43M | 25.84M | 25.84M | 25.79M | n/a | n/a | n/a | n/a | -5.05K | 19.24M | 19.24M | 57.61M | 63.96M | 50.59M | 52.87M |
Net Cash Flow | 797K | -340K | 1.31M | -16.37M | -336K | 623K | -1.87M | 12.97M | -2.33M | 41K | -935K | 2.05M | -4.36M | -49.07M | -50.17M | -55M | -31.97M | 7.5M | 45.39M | 52.27M | 38.66M | 42.31M |
Free Cash Flow | -14.62M | -14.79M | -15.57M | -17.24M | -17.13M | -17.33M | -16.87M | -16.74M | -16.67M | -17.34M | -18.89M | -17.78M | -18.06M | -17.46M | -15.73M | -15.03M | -12.92M | -11.74M | -12.21M | -11.69M | -11.92M | -10.57M |
Adj. Free Cash Flow | -16.81M | -18.03M | -18.99M | -21.04M | -21.25M | -21.01M | -21.02M | -21.01M | -21.04M | -21.86M | -24.09M | -24.07M | -25.46M | -26M | -24.73M | -27.13M | -23.14M | -19.85M | -18.21M | -12.86M | -12.97M | -11.45M |
Maintenance CapEx | n/a | -5K | -5K | -9K | -18K | -27K | -37K | -37K | -31K | -38K | -33K | -38K | -49K | -51K | -115K | -170.75K | -308.75K | -412.75K | -367.75K | -330.54K | -203.51K | -198.98K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -14.62M | -14.79M | -15.57M | -17.24M | -17.13M | -17.33M | -16.87M | -16.74M | -16.67M | -17.34M | -18.89M | -17.78M | -18.06M | -17.46M | -15.73M | -15.03M | -12.92M | -11.74M | -12.21M | -11.69M | -11.92M | -10.57M |
Add to Watchlist
Select watchlists to add or remove NVNO